ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Group A and C Meningococcal Polysaccharide Vaccine Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-18I18043
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Group A and C Meningococcal Polysaccharide Vaccine Market Research Report 2024
BUY CHAPTERS

Global Group A and C Meningococcal Polysaccharide Vaccine Market Research Report 2024

Code: QYRE-Auto-18I18043
Report
August 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
GlaxoSmithKline
Sanofi Pasteur
Pfizer Inc
Merck
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biological
Walvax
AIM Bio
Lanzhou Institute of Biological Products
CanSino Biologics
Sinovac
Toyouvax
Chengda Biotechnology

Group A and C Meningococcal Polysaccharide Vaccine Market

The global Group A and C Meningococcal Polysaccharide Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Group A and C Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Group A and C Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Group A and C Meningococcal Polysaccharide Vaccine include Pfizer, Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Royal (Wuxi) Bio-Pharmaceutical, Zhifei Biological, Toyouvax, Walvax, AIM Bio, Lanzhou Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Group A and C Meningococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Group A and C Meningococcal Polysaccharide Vaccine.
The Group A and C Meningococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Group A and C Meningococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Group A and C Meningococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Group A and C Meningococcal Polysaccharide Vaccine Market Report

Report Metric Details
Report Name Group A and C Meningococcal Polysaccharide Vaccine Market
Segment by Type
Segment by Application
  • Hospital
  • Centers for Disease Control and Prevention
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Royal (Wuxi) Bio-Pharmaceutical, Zhifei Biological, Toyouvax, Walvax, AIM Bio, Lanzhou Institute of Biological Products, Cansino Biologics, Chengda Biotechnology, Sinovac
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Group A and C Meningococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Group A and C Meningococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Group A and C Meningococcal Polysaccharide Vaccine Market report?

Ans: The main players in the Group A and C Meningococcal Polysaccharide Vaccine Market are Pfizer, Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Royal (Wuxi) Bio-Pharmaceutical, Zhifei Biological, Toyouvax, Walvax, AIM Bio, Lanzhou Institute of Biological Products, Cansino Biologics, Chengda Biotechnology, Sinovac

What are the Application segmentation covered in the Group A and C Meningococcal Polysaccharide Vaccine Market report?

Ans: The Applications covered in the Group A and C Meningococcal Polysaccharide Vaccine Market report are Hospital, Centers for Disease Control and Prevention, Others

What are the Type segmentation covered in the Group A and C Meningococcal Polysaccharide Vaccine Market report?

Ans: The Types covered in the Group A and C Meningococcal Polysaccharide Vaccine Market report are Polysaccharide Vaccine, Polysaccharide-protein Conjugate Vaccine

Recommended Reports

Meningococcal Vaccines

Conjugate Vaccines

General Vaccine Market

1 Group A and C Meningococcal Polysaccharide Vaccine Market Overview
1.1 Product Definition
1.2 Group A and C Meningococcal Polysaccharide Vaccine by Type
1.2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Polysaccharide Vaccine
1.2.3 Polysaccharide-protein Conjugate Vaccine
1.3 Group A and C Meningococcal Polysaccharide Vaccine by Application
1.3.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Centers for Disease Control and Prevention
1.3.4 Others
1.4 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue 2019-2030
1.4.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales 2019-2030
1.4.3 Global Group A and C Meningococcal Polysaccharide Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Group A and C Meningococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Group A and C Meningococcal Polysaccharide Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Group A and C Meningococcal Polysaccharide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Group A and C Meningococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Group A and C Meningococcal Polysaccharide Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Group A and C Meningococcal Polysaccharide Vaccine, Date of Enter into This Industry
2.8 Global Group A and C Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.8.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Group A and C Meningococcal Polysaccharide Vaccine Players Market Share by Revenue
2.8.3 Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Group A and C Meningococcal Polysaccharide Vaccine Market Scenario by Region
3.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region: 2019-2030
3.2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region: 2019-2024
3.2.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region: 2025-2030
3.3 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue by Region: 2019-2030
3.3.1 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue by Region: 2019-2024
3.3.2 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue by Region: 2025-2030
3.4 North America Group A and C Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.4.3 North America Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Group A and C Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.5.3 Europe Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Group A and C Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2019-2030)
4.1.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2019-2024)
4.1.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2025-2030)
4.1.3 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue by Type (2019-2030)
4.2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue by Type (2019-2024)
4.2.2 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue by Type (2025-2030)
4.2.3 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Group A and C Meningococcal Polysaccharide Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2019-2030)
5.1.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2019-2024)
5.1.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2025-2030)
5.1.3 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue by Application (2019-2030)
5.2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue by Application (2019-2024)
5.2.2 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue by Application (2025-2030)
5.2.3 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Group A and C Meningococcal Polysaccharide Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Company Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Merck & Co.
6.4.1 Merck & Co. Company Information
6.4.2 Merck & Co. Description and Business Overview
6.4.3 Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.4.5 Merck & Co. Recent Developments/Updates
6.5 Royal (Wuxi) Bio-Pharmaceutical
6.5.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
6.5.2 Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
6.5.3 Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.5.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
6.6 Zhifei Biological
6.6.1 Zhifei Biological Company Information
6.6.2 Zhifei Biological Description and Business Overview
6.6.3 Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.6.5 Zhifei Biological Recent Developments/Updates
6.7 Toyouvax
6.7.1 Toyouvax Company Information
6.7.2 Toyouvax Description and Business Overview
6.7.3 Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.7.5 Toyouvax Recent Developments/Updates
6.8 Walvax
6.8.1 Walvax Company Information
6.8.2 Walvax Description and Business Overview
6.8.3 Walvax Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Walvax Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.8.5 Walvax Recent Developments/Updates
6.9 AIM Bio
6.9.1 AIM Bio Company Information
6.9.2 AIM Bio Description and Business Overview
6.9.3 AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.9.5 AIM Bio Recent Developments/Updates
6.10 Lanzhou Institute of Biological Products
6.10.1 Lanzhou Institute of Biological Products Company Information
6.10.2 Lanzhou Institute of Biological Products Description and Business Overview
6.10.3 Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.10.5 Lanzhou Institute of Biological Products Recent Developments/Updates
6.11 Cansino Biologics
6.11.1 Cansino Biologics Company Information
6.11.2 Cansino Biologics Description and Business Overview
6.11.3 Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.11.5 Cansino Biologics Recent Developments/Updates
6.12 Chengda Biotechnology
6.12.1 Chengda Biotechnology Company Information
6.12.2 Chengda Biotechnology Description and Business Overview
6.12.3 Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.12.5 Chengda Biotechnology Recent Developments/Updates
6.13 Sinovac
6.13.1 Sinovac Company Information
6.13.2 Sinovac Description and Business Overview
6.13.3 Sinovac Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
6.13.5 Sinovac Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Group A and C Meningococcal Polysaccharide Vaccine Industry Chain Analysis
7.2 Group A and C Meningococcal Polysaccharide Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Group A and C Meningococcal Polysaccharide Vaccine Production Mode & Process
7.4 Group A and C Meningococcal Polysaccharide Vaccine Sales and Marketing
7.4.1 Group A and C Meningococcal Polysaccharide Vaccine Sales Channels
7.4.2 Group A and C Meningococcal Polysaccharide Vaccine Distributors
7.5 Group A and C Meningococcal Polysaccharide Vaccine Customers
8 Group A and C Meningococcal Polysaccharide Vaccine Market Dynamics
8.1 Group A and C Meningococcal Polysaccharide Vaccine Industry Trends
8.2 Group A and C Meningococcal Polysaccharide Vaccine Market Drivers
8.3 Group A and C Meningococcal Polysaccharide Vaccine Market Challenges
8.4 Group A and C Meningococcal Polysaccharide Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
GlaxoSmithKline
Sanofi Pasteur
Pfizer Inc
Merck
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biological
Walvax
AIM Bio
Lanzhou Institute of Biological Products
CanSino Biologics
Sinovac
Toyouvax
Chengda Biotechnology
List of Tables
 Table 1. Global Group A and C Meningococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Group A and C Meningococcal Polysaccharide Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Group A and C Meningococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose) of Key Manufacturers (2019-2024)
 Table 5. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Group A and C Meningococcal Polysaccharide Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Group A and C Meningococcal Polysaccharide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Group A and C Meningococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Group A and C Meningococcal Polysaccharide Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Group A and C Meningococcal Polysaccharide Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Group A and C Meningococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group A and C Meningococcal Polysaccharide Vaccine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (Dose)
 Table 18. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
 Table 19. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2025-2030) & (Dose)
 Table 20. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2025-2030)
 Table 21. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2019-2024)
 Table 23. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2025-2030)
 Table 25. North America Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Dose)
 Table 27. North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (Dose)
 Table 28. North America Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Dose)
 Table 32. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (Dose)
 Table 33. Europe Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (Dose)
 Table 37. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2025-2030) & (Dose)
 Table 38. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Dose)
 Table 42. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (Dose)
 Table 43. Latin America Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Dose)
 Table 47. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (Dose)
 Table 48. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose) by Type (2019-2024)
 Table 51. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose) by Type (2025-2030)
 Table 52. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
 Table 53. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2025-2030)
 Table 54. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
 Table 57. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2025-2030)
 Table 58. Global Group A and C Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Group A and C Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose) by Application (2019-2024)
 Table 61. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose) by Application (2025-2030)
 Table 62. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
 Table 63. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2025-2030)
 Table 64. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2024)
 Table 67. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2025-2030)
 Table 68. Global Group A and C Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Group A and C Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2025-2030)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Sanofi Pasteur Company Information
 Table 76. Sanofi Pasteur Description and Business Overview
 Table 77. Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 79. Sanofi Pasteur Recent Developments/Updates
 Table 80. GlaxoSmithKline Company Information
 Table 81. GlaxoSmithKline Description and Business Overview
 Table 82. GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 84. GlaxoSmithKline Recent Developments/Updates
 Table 85. Merck & Co. Company Information
 Table 86. Merck & Co. Description and Business Overview
 Table 87. Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 89. Merck & Co. Recent Developments/Updates
 Table 90. Royal (Wuxi) Bio-Pharmaceutical Company Information
 Table 91. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
 Table 92. Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 94. Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
 Table 95. Zhifei Biological Company Information
 Table 96. Zhifei Biological Description and Business Overview
 Table 97. Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 98. Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 99. Zhifei Biological Recent Developments/Updates
 Table 100. Toyouvax Company Information
 Table 101. Toyouvax Description and Business Overview
 Table 102. Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 103. Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 104. Toyouvax Recent Developments/Updates
 Table 105. Walvax Company Information
 Table 106. Walvax Description and Business Overview
 Table 107. Walvax Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 108. Walvax Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 109. Walvax Recent Developments/Updates
 Table 110. AIM Bio Company Information
 Table 111. AIM Bio Description and Business Overview
 Table 112. AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 113. AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 114. AIM Bio Recent Developments/Updates
 Table 115. Lanzhou Institute of Biological Products Company Information
 Table 116. Lanzhou Institute of Biological Products Description and Business Overview
 Table 117. Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 118. Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 119. Lanzhou Institute of Biological Products Recent Developments/Updates
 Table 120. Cansino Biologics Company Information
 Table 121. Cansino Biologics Description and Business Overview
 Table 122. Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 123. Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 124. Cansino Biologics Recent Developments/Updates
 Table 125. Chengda Biotechnology Company Information
 Table 126. Chengda Biotechnology Description and Business Overview
 Table 127. Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 128. Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 129. Chengda Biotechnology Recent Developments/Updates
 Table 130. Sinovac Company Information
 Table 131. Sinovac Description and Business Overview
 Table 132. Sinovac Group A and C Meningococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 133. Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product
 Table 134. Sinovac Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Group A and C Meningococcal Polysaccharide Vaccine Distributors List
 Table 138. Group A and C Meningococcal Polysaccharide Vaccine Customers List
 Table 139. Group A and C Meningococcal Polysaccharide Vaccine Market Trends
 Table 140. Group A and C Meningococcal Polysaccharide Vaccine Market Drivers
 Table 141. Group A and C Meningococcal Polysaccharide Vaccine Market Challenges
 Table 142. Group A and C Meningococcal Polysaccharide Vaccine Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Group A and C Meningococcal Polysaccharide Vaccine
 Figure 2. Global Group A and C Meningococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Type: 2023 & 2030
 Figure 4. Polysaccharide Vaccine Product Picture
 Figure 5. Polysaccharide-protein Conjugate Vaccine Product Picture
 Figure 6. Global Group A and C Meningococcal Polysaccharide Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Centers for Disease Control and Prevention
 Figure 10. Others
 Figure 11. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (2019-2030) & (Dose)
 Figure 14. Global Group A and C Meningococcal Polysaccharide Vaccine Average Price (US$/Dose) & (2019-2030)
 Figure 15. Group A and C Meningococcal Polysaccharide Vaccine Report Years Considered
 Figure 16. Group A and C Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2023
 Figure 17. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Group A and C Meningococcal Polysaccharide Vaccine Players: Market Share by Revenue in Group A and C Meningococcal Polysaccharide Vaccine in 2023
 Figure 19. Group A and C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
 Figure 22. North America Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)
 Figure 23. United States Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
 Figure 26. Europe Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2019-2030)
 Figure 34. China Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Group A and C Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Group A and C Meningococcal Polysaccharide Vaccine by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Group A and C Meningococcal Polysaccharide Vaccine by Type (2019-2030)
 Figure 53. Global Group A and C Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Group A and C Meningococcal Polysaccharide Vaccine by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Group A and C Meningococcal Polysaccharide Vaccine by Application (2019-2030)
 Figure 56. Global Group A and C Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2019-2030)
 Figure 57. Group A and C Meningococcal Polysaccharide Vaccine Value Chain
 Figure 58. Group A and C Meningococcal Polysaccharide Vaccine Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Meningococcal Group A and C Conjugate Vaccine Market Research Report 2024
Global Meningococcal Polysaccharide Vaccine Market Research Report 2025
Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Research Report 2025
Meningococcal Disease Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024
Meningococcal Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meningitis Vaccine Market Research Report 2025
Global Meningococcal Infections Vaccine Market Insights Forecast to 2030
Global Prevent Meningitis Vaccine Market Research Report 2025
Meningococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global 13 Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Research Report 2024
Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Research Report 2025
Global Adult Vaccines Market Research Report 2024
Global Neisseria meningitidis Infections Drug Market Research Report 2024
Global Meningococcal Infections Treatment Market Research Report 2024
Global Streptococcus Group A Antibodies Market Research Report 2024
Global Adult and Pediatric Vaccines Market Research Report 2024
Global Mannooligosaccharides Market Research Report 2025
Human Vaccine Adjuvants Market
Global Vaccines for the Elderly Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions